BIT's 17th Annual Congress of International Drug Discovery Science and Technology (IDDST-2019)
Conference Report of IDDST-2019

BIT's 17th Annual Congress of International Drug Discovery Science and Technology-2019 (IDDST-2019) which was held in Kyoto International Conference Center on July 25-27, achieved a consummation. Our conference was hosted by BIT Group Global Ltd., supported by Japan Pharmaceutical Manufacturers Association, Axcelead Drug Discovery Partners, Inc., UK Pharmacogenetics and Stratified Medicine Network, The Czech Pharmaceutical Society and The Center for the Biology of Chronic Disease. Over 300 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Dr. Xiaodan Mei, President, BIT Group Global Ltd., China; Dr. Yoshinori Ikeura, CEO, Axcelead Drug Discovery Partners, Inc., Japan; Dr. Matthias von Herrath, Professor, La Jolla Institute; Vice President, NovoNordisk, USA; Dr. Zhuo Li, General Manager, NanoTemper Technologies, China; Dr. Kazuhide Inoue, EVP & Professor, Kyushu University, Japan; Dr. Loui Madakamutil, SVP, Head of Discovery, Nektar Therapeutics, USA; Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK…etc.

This annual congress comprised of 30 sessions following the ceremony, including “Drug Discovery S & T “, “Breaking Preclinical and Clinical Research"; “Last Stage Drug Discovery"; “New Biotherapy Discovery"…etc.

This annual conference brought together 400 specialists from 36 countries and areas, which was devoted to the leading issues and popular topics and provide up-to-date information to all over the world. In welcome banquet, all guests appreciated and joined in the brilliant Japanese traditional performances, also expressed sincerely congratulation to successful IDDST-2019. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing IDDST-2020 which would be better and more successful. All of us are looking forward to meeting you again in 2020.

Keynote Speakers
说明: https://media.licdn.com/dms/image/C4D03AQGfIHSVDh04_g/profile-displayphoto-shrink_800_800/0?e=1542844800&v=beta&t=DBlrhcpRkTvnqCBUlR2IyQ2IHLIDpHfKDyzgArPrSEw Dr. Yoshinori Ikeura, CEO/CSO, Axcelead Drug Discovery Partners, Inc., Japan 说明: https://www.lji.org/wp-content/uploads/2015/12/MatthiasvonHerrath.png Dr. Matthias von Herrath, Professor, La Jolla Institute; Vice President, NovoNordisk, USA
说明: http://www.ims.u-tokyo.ac.jp/imsut/files/lab/Cancer/murakami.jpg Dr. Kazuhide Inoue, Professor, Kyushu University, Japan Dr. Loui Madakamutil, SVP, Head of Discovery, Nektar Therapeutics, USA
Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK Dr. Zhuo Li, General Manager, NanoTemper Technologies, China
Confirmed Renowned Speakers
说明: Dr. Benno Rattel Dr. Benno Rattel, Executive Director, Nonclinical Development, Amgen Research, Germany 说明: Jonathan Zalevsky Dr. Jonathan Zalevsky, Senior Vice President, CSO, Research, Nektar Therapeutics, USA 说明: Henry He Sun Dr. Alexey RAK, Director of Bio Structure and Biophysics, Sanofi R&D, France
说明: Tord Labuda Dr. Tord Labuda, Vice President R&D, LEO Pharma K.K., Japan 说明: Mitsuo Satoh Dr. Le Sun, President, AbMax Biotechnology Co., Ltd., China 说明: Zhuo Li Dr. Angelito Jonas L. Kalaw, Medical Director, PAREXEL International, Australia
说明: 查看源图像 Dr. Balazs Sarkadi, Professor, Semmelweis University, Hungary Laszlo Takacs Dr. Laszlo Takacs,
Professor, University of Debrecen, Hungary
说明: 查看源图像 Dr. Yukio Yoneda, Professor Emeritus, Kanazawa University, Japan
说明: Helmut Thomas Dr. Anthony W. Coleman, Research Director, Université de Lyon, France 说明: James Legg Dr. James Legg, Vice President, Research and Development, Crescendo Biologics Ltd., UK 说明: Meredith Rocca Dr. Meredith Rocca,Senior Scientific Director, Biologics Toxicology, Janssen R & D, USA
说明: Mircea Ciuca.jpg Dr. Mircea Ciuca, Global Head Medical & Clinical Drug Safety, Vifor Pharma, Switzerland 说明: 查看源图像 Dr. Amrik Basran, CSO, Avacta Life Sciences, UK 说明: daniel fleischanderl Dr. Frank S. Walsh, CEO, Ossianix, Inc., USA
说明: http://beta.chem.uw.edu.pl/people/KJackowski/foto.bmp Dr. Karol Jackowski, Professor of Chemistry, University of Warsaw, Poland 说明: https://unitedscientificgroup.com/conferences/pharma/images/Hiroshi-Maruta.jpg Dr. Hiroshi Maruta, Professor, PAK Research Center,  Australia 说明: http://www.iddst.com/uploadfile/2018012515162273499.bmp Dr. Yaakov Naparstek, Professor of Medicine, Hadassah University Hospital, Israel
说明: Colin O'Dowd Dr. Richard C Bethell, Chief Scientific Officer, Medivir AB, Sweden 说明: Dr Mahmood Moshiri Dr. Aruna Dontabhaktuni, President & CEO, PharmaPro Consulting, USA Maria Gonzalez-Pajuelo Dr. Maria Fardis,
President & CEO, Iovance Biotherapeutics, USA
说明: denk_richard_backdrop_6x6.jpg Dr. Richard Denk, Head Sales Containment, SKAN AG, Switzerland 说明: Robert Plumb Dr. Robert S. Plumb, Director Omics Sciences, Scientific Operations, Waters Corporation, USA 说明: Dr.Graham Ball Dr. Graham R. Ball, Professor/CSO, Nottingham Trent University/CompanDX, UK
Dr. Ilya B. Tsyrlov, President and CSO, Xenotox Inc, USA 说明: Jacintha Shenton Dr. Jacintha Shenton, Scientific Director, Biologics Toxicology, Janssen R&D, USA Dr. Maier C William, CSO, ICON PLC, UK
说明: Kang Li Dr. Kang Li, Head of Biologics, BeiGene, China 说明: Martine Zimmermann Dr. Florian Montel, Head of opnMe.com & CNS Project Leader, Boehringer Ingelheim, Germany 说明: m_074[1].jpg Dr. Eiichi Saitoh, Professor, Niigata Institute of Technology, Japan
说明: L. Madakamutil Proofs-7.jpg Dr. Domingo Gargallo-Viola, CSO, ABAC Therapeutics, Spain 说明: Lee Gethings Dr. Lee Gethings, Senior Manager, Waters Corporation, UK 说明: Gail Adinamis Dr. Gail Adinamis, CEO, GlobalCare Clinical Trials, Ltd., USA
http://www.lyg.gov.cn/zglygzfmhwz/upload/ueditor/1509418357922.jpg Dr. Yinsheng Zhang, Senior Director, Chia Tai Tianqing Pharmaceutical Group Co.,China Dr. Xiao Feng,
President of R&D Center, GeneScience Pharmaceuticals Co., Ltd, China
Igor Sherman Dr. Jeffrey Hung,
CCO and GM, Vigene Biosciences, USA
Scenery of Kyoto

Kyoto, literally "Capital City", is a city located in the central part of the island of Honshu, Japan. It has a population close to 1.5 million. Kyoto is the most well known capital of Japan in Japanese history for more than one thousand years, it is now the capital city of Kyoto Prefecture located in the Kansai region, as well as a major part of the Kyoto-Osaka-Kobe metropolitan area.

Conference Guide
Hosting Organization
Foreign Experts Databank of SAFEA-Dalian Branch
Conference Chair

Dr. Yoshinori Ikeura,
CEO/CSO, Axcelead Drug Discovery Partners, Inc., Japan

Supporting Organizations


Japan Pharmaceutical Manufacturers Association




Axcelead Drug Discovery Partners, Inc.




UK Pharmacogenetics and Stratified Medicine Network



The National Hospital Pharmacists Association of Romanian



The Czech Pharmaceutical Society 



The Center for the Biology of Chronic Disease

Sponsor


NanoTemper Technologies GmbH
Exhibitors


NanoTemper Technologies GmbH


BioAgilytix Labs


Nihon Validation Technologies Corporation


Japan Pharmaceutical Manufacturers Association


GlobalCare Clinical Trials, Ltd.


Sygnature Discovery Limited
Media Partner List
BIT's Upcoming Events

© 2003-2019 All rights reserved by BIT Group Global Ltd.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897